2025 Basics Bootcamp: Women's Wellness: Hormones, the Pause, and Sexual Health for Gyn Cancer Survivors
Log in to see your correct pricing, as early-bird pricing is open through October 19! SGO members receive a discount. Content will become available by October 20.
This bootcamp covers essential topics including the physiology of menopause, hormone therapy guidelines for gynecologic cancer survivors and previvors, basic management of hormone therapy, non-hormonal approaches to managing menopause, and key aspects of sexual health. Special attention will be given to managing genitourinary syndrome of menopause (GSM), exploring both hormonal and non-hormonal treatment options, and addressing conditions such as vulvodynia and dyspareunia. Providers will gain practical strategies to optimize quality of life and support holistic care for patients throughout cancer treatment and beyond.
2.75 CE is available for this content through April 20, 2026. It is recommended for any clinician interested in becoming more competent in menopause and sexual health management for gynecologic cancer survivors. Registration provides access to PDFs of presentation slides and recordings of the live presentations given on Friday, October 10, in conjunction with the SGO 2025 Allied Health Professionals Meeting.
Target Audience
NPs, PAs, APPs, Allied Health Professionals
Learning Objectives
Explain the physiology of menopause and apply current hormone therapy guidelines for gynecologic cancer survivors and previvors.
Identify and implement both hormonal and non-hormonal strategies for managing menopause-related symptoms, including genitourinary syndrome of menopause (GSM), vulvodynia, and dyspareunia.
Integrate evidence-based approaches to support sexual health and enhance quality of life for patients during and after cancer treatment through holistic, patient-centered care.
Additional Information
| Attachment | Size |
|---|---|
| 495.14 KB |
Available Credit
- 2.75 AMA PRA Category 1 Credit™In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this Enduring material for a maximum of 2.75 Enduring AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 2.75 AMA PRA Category 1 Credits™- For Non-physiciansIn support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PAs may claim a maximum of 2.75 Enduring Category 1 credits for completing this activity. - 2.75 CNE Contact HoursIn support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this activity for a maximum of 2.75 Enduring ANCC contact hours. - 2.75 Participation

Facebook
X
LinkedIn
Forward